Ostarine would be the closest SARM to staying approved in medicine and is also at this time in section II scientific trials. Like SARMs in general, MK-2866 targets androgen receptors on the selective basis and avoids producing the forms of hazardous side effects involved with substances like testosterone, human growth https://irvingw825xhs2.ja-blog.com/profile